Search

Huntington's disease (HD) is an inherited neurodegenerative disease characterized by neuropsychiatric symptoms including chorea, dementia, and depression. It is inherited in an autosomal dominant fashion and exhibits anticipation leading to earlier and more severe symptoms in the affected offspring of a patient. With a much lower prevalence in Asia than in Europe and other parts of the world, its diagnosis can be missed easily in the early stages due to mildness of the symptoms and significant overlap between its symptoms and those of other diseases. We present the case of a 38-year-old male of Pashtun ethnicity presenting with mild cognitive impairment and clumsiness who was eventually diagnosed with HD, but his mild clinical features, no documented history of HD in his parents, and his relatively young age coupled with the relatively low prevalence of HD in his geographical location presented a significant challenge in our diagnosis of his condition. This case underscores the importance of keeping a high clinical suspicion for HD in patients with chorea despite a negative parental history, especially in resource-limited areas where the parents may have gone undiagnosed and highlights the need for further research on HD's prevalence in different parts of the world as well as the barriers to its diagnosis. [ABSTRACT FROM AUTHOR]

Background: Chronic obstructive pulmonary disease (COPD) is a major cause of global morbidity and mortality, with acute exacerbations significantly worsening patient outcomes. These exacerbations often lead to hospitalizations and increased healthcare costs. Proper management, guided by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, is essential to improving care. However, real-world adherence to these recommendations can vary. Objective: To assess how acute COPD exacerbations were handled at a tertiary care hospital of Peshawar. Methodology: In the emergency department of Hayatabad Medical Complex Peshawar, between November 2021 and December 2023, we retrospectively examined clinical data of patients presenting with acute exacerbations of COPD. The management was assessed in light of the GOLD 2019 report's and earlier audits' recommendations. Results: Total 170 patients (mean age 73 years, range 41-95 years, 54% male) were included. GOLD risk group (A-D) was only documented in 39% of the cases. At the time of presentation, 74% of the patients had their respiratory rate evaluated, and 69% had their blood gas analysis done. In all, 95% of the patients had chest imaging performed. Short-acting bronchodilators were used as initial symptomatic management in 56% of cases. Among them, 92% had systemic steroid therapy implemented. Conclusion: The GOLD guidelines were not fully followed, particularly in relation to non-invasive breathing, early symptomatic treatment, and severity assessment. These findings highlight the significance of periodic practice revisions on a regular basis, which may raise practitioners' knowledge and enhance the standard of COPD care in the long run. [ABSTRACT FROM AUTHOR]